Literature DB >> 17120482

Re-emerging poliomyelitis--is Australia's surveillance adequate?

David N Durrheim, I Peter Massey, Heath Kelly.   

Abstract

In the past two years there has been a resurgence of polio with 21 previously polio-free countries importing wild poliovirus. Wild poliovirus importations into polio-free areas will continue to occur until endemic transmission is interrupted globally. Australia's acute flaccid paralysis (AFP) surveillance falls well short of the target of more than 80 per cent of AFP cases having two adequate stool specimens taken at least 24 hours apart within 14 days of onset for poliovirus examination. As most AFP cases are hospitalised, AFP should be immediately notifiable by hospitals to public health units or state or territory public health authorities to ensure appropriate follow up, including stool specimens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120482

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  4 in total

1.  Imported case of poliomyelitis, Melbourne, Australia, 2007.

Authors:  Andrew J Stewardson; Jason A Roberts; Carolyn L Beckett; Hayden T Prime; Poh-Sien Loh; Bruce R Thorley; John R Daffy
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

2.  An evaluation of the sensitivity of acute flaccid paralysis surveillance for poliovirus infection in Australia.

Authors:  Rochelle E Watkins; P Anthony J Martin; Heath Kelly; Ben Madin; Charles Watson
Journal:  BMC Infect Dis       Date:  2009-09-30       Impact factor: 3.090

3.  Public health response to imported case of poliomyelitis, Australia, 2007.

Authors:  John A Carnie; Rosemary Lester; Rodney Moran; Lynne Brown; Julian Meagher; Jason A Roberts; Bruce R Thorley
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

4.  Potential for the Australian and New Zealand paediatric intensive care registry to enhance acute flaccid paralysis surveillance in Australia: a data-linkage study.

Authors:  Linda K Hobday; Bruce R Thorley; Janet Alexander; Thomas Aitken; Peter D Massey; Michelle Cretikos; Anthony Slater; David N Durrheim
Journal:  BMC Infect Dis       Date:  2013-08-21       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.